Fingerprint
Dive into the research topics of 'A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
Tiffini Voss, Richard B. Lipton, David W. Dodick, Nicole Dupre, Joy Yang Ge, Robert Bachman, Christopher Assaid, Sheena K. Aurora, David Michelson
Research output: Contribution to journal › Article › peer-review
204
Scopus
citations